ArticleTherapeutic advances in medical oncology2018

Neoadjuvant treatment of HER2-positive breast cancer: should therapy differ based on hormone receptor status?

Nadia HarbeckPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.